We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
(-4.3%)
Cap. Flow
-$587M
Cap. Flow
% of AUM
-4.35%
Top 10 Holdings %
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$30.1M |
| 2 |
Energy Transfer Partners
ET
|
+$24.7M |
| 3 |
Franklin FTSE Japan ETF
FLJP
|
+$11.8M |
| 4 |
Wells Fargo
WFC
|
+$9.66M |
| 5 |
Alkermes
ALKS
|
+$8.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$49.8M |
| 2 |
Enterprise Products Partners
EPD
|
+$49.1M |
| 3 |
Western Midstream Partners
WES
|
+$44.8M |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$42.5M |
| 5 |
EQM
EQM Midstream Partners, LP
EQM
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.41% |
| 2 | Financials | 7.05% |
| 3 | Healthcare | 3.6% |
| 4 | Consumer Discretionary | 3.1% |
| 5 | Technology | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Tesla
TSLA
$1.24T
| $3.51M | 0.03% |
235,695
+153,750
| +188% | +$2.39M |
|
177
Itron
ITRI
$3.73B
| $3.42M | 0.03% |
54,645
+26,944
| +97% | +$1.5M |
|
178
Madrigal Pharmaceuticals
MDGL
$12.6B
| $3.38M | 0.03% |
32,273
-4,907
| -13% | -$526K |
|
|
APLS
179
DELISTED
Apellis Pharmaceuticals
APLS
| $3.35M | 0.02% |
132,351
-3,497
| -3% | -$71.1K |
|
180
Procter & Gamble
PG
$343B
| $3.35M | 0.02% |
30,516
-5,019
| -14% | -$535K |
|
|
PEGI
181
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $3.32M | 0.02% |
143,812
+65,417
| +83% | +$1.46M |
|
182
Ormat Technologies
ORA
$6.11B
| $3.29M | 0.02% |
51,890
+24,175
| +87% | +$1.44M |
|
|
CVA
183
DELISTED
Covanta Holding Corporation
CVA
| $3.26M | 0.02% |
181,903
+90,963
| +100% | +$1.6M |
|
184
Merck
MRK
$324B
| $3.23M | 0.02% |
40,317
+5,527
| +16% | +$423K |
|
185
AnaptysBio
ANAB
$1.6B
| $3.19M | 0.02% |
56,563
-8,053
| -12% | -$580K |
|
186
Wolfspeed
WOLF
$1.2B
| $3.16M | 0.02% |
56,261
+28,128
| +100% | +$1.72M |
|
187
Hecla Mining
HL
$10.2B
| $3.15M | 0.02% |
1,752,151
+1,361,747
| +349% | +$2.49M |
|
188
Nike
NKE
$61.9B
| $3.14M | 0.02% |
37,419
-1,520
| -4% | -$128K |
|
189
Gossamer Bio
GOSS
$66.5M
| $3.06M | 0.02% |
+137,925
| New | +$2.64M |
|
190
Sunrun
RUN
$2.37B
| $3.05M | 0.02% |
162,650
+82,215
| +102% | +$1.34M |
|
191
Sibanye-Stillwater
SBSW
$5.92B
| $2.94M | 0.02% |
620,104
-864,971
| -58% | -$3.43M |
|
192
Schwab US TIPS ETF
SCHP
$16.3B
| $2.92M | 0.02% |
103,542
+1,018
| +1% | +$28.2K |
|
193
Equinix
EQIX
$107B
| $2.87M | 0.02% |
5,686
-213
| -4% | -$102K |
|
194
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $2.84M | 0.02% |
27,951
+535
| +2% | +$54.3K |
|
195
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $2.8M | 0.02% |
99,298
+51,425
| +107% | +$1.37M |
|
|
ORTX
196
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.78M | 0.02% |
+19,855
| New | +$3.49M |
|
197
Fate Therapeutics
FATE
$281M
| $2.77M | 0.02% |
136,434
-19,404
| -12% | -$350K |
|
198
McEwen Inc
MUX
$1.03B
| $2.73M | 0.02% |
156,095
-3,541
| -2% | -$51.8K |
|
199
Enphase Energy
ENPH
$4.84B
| $2.71M | 0.02% |
148,820
+76,899
| +107% | +$1.06M |
|
|
RARX
200
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.66M | 0.02% |
+88,545
| New | +$2.03M |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.
- ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
- ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
- ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
- ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
- ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
- ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
- ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.
Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.